Screener
Vivani Medical VANI EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Vivani Medical in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Vivani Medical’s 10-Q, filed August 13, 2026.
- Filed
- Aug 13, 2026, 4:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001753926-26-001477
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Research and development, net of grants | $4,456 | $4,759 | $8,957 | $8,976 |
| General and administrative, net of grants | 2,418 | 2,703 | 4,864 | 5,044 |
| Total operating expenses | 6,874 | 7,462 | 13,821 | 14,020 |
| Loss from operations | (6,874) | (7,462) | (13,821) | (14,020) |
| Other income, net | 504 | 318 | 671 | 574 |
| Net loss | $(6,370) | $(7,144) | $(13,150) | $(13,446) |
| Net loss per common share - basic and diluted | $(0.07) | $(0.12) | $(0.16) | $(0.23) |
| Weighted average shares outstanding - basic and diluted | 87,090 | 59,244 | 84,196 | 59,240 |
Document
FAQ
- What is Vivani Medical's EPS (diluted)?
- Vivani Medical (VANI) reported EPS (diluted) of -$0.07 in Q2 2026.
- How has Vivani Medical's EPS (diluted) changed year-over-year?
- Vivani Medical's EPS (diluted) increased by 41.7% year-over-year, from -$0.12 to -$0.07.
- What is the long-term trend for Vivani Medical's EPS (diluted)?
- Over 3 years (2021 to 2025), Vivani Medical's EPS (diluted) has grown at a 9.2% compound annual growth rate (CAGR), from -$0.33 to -$0.43.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Vivani Medical's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude